<DOC>
	<DOCNO>NCT02547337</DOCNO>
	<brief_summary>Type 1 diabetes major type diabetes young . The pathophysiology still need clarification order reach feasible mean prevent disease . This study aim define difference pancreatic intestinal blood flow subject without type 1 diabetes validate methodology achieve . Earlier animal study demonstrate change pancreatic islet blood flow use microspheres . The aim study test validate method assessment islet perfusion human use molecular imaging . The investigator hypothesize glucose-stimulated pancreatic perfusion enhance specifically islets healthy subject increase mostly suppressed subject type 1 diabetes . Positron emission tomography ( PET ) non-invasive imaging technique , use study flow metabolism different organ . Using radiowater ( [ 15O ] H2O ) PET , cellular perfusion measure directly noninvasively . Recently , diffusion weight magnetic resonance imaging ( DWI ) also apply complimentary method assessment quantitate change pancreatic blood flow . In study 10 healthy subject 10 subject type 1 diabetes image two separate day . Pancreatic intestinal perfusion first measure [ 15O ] H2O combine PET/magnetic resonance image 5 15 minute intravenous glucose infusion . On second day , PET image replaced dynamic DWI conduct time schedule intravenous glucose stimulation .</brief_summary>
	<brief_title>Glucose-stimulated Pancreatic Islet Intestinal Blood Flow Healthy Subjects Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Criteria healthy subject Inclusion criterion Healthy judge history examination Age 1830 year Body mass index ( BMI ) 18 27 kg/m2 Normal 2 h oral glucose tolerance test Exclusion criterion Any chronic disease Pregnancy Blood pressure &gt; 140/90 mmHg Smoking Presence ferromagnetic object body Any condition could possibly create hazard subject safety , endanger study procedure interfere interpretation study result Criteria subject type 1 diabetes ( T1D ) Inclusion criterion T1D diagnose least 5 year ago Age 1830 year BMI 18 30 kg/m2 Good moderate glycemic control longacting insulin analogue combine injection rapidacting insulin Uncomplicated T1D minor microvascular complication Exclusion criterion Any condition disease possibly affect circulation , evaluate physician Pregnancy Blood pressure &gt; 140/90 mmHg Smoking Presence ferromagnetic object body Any condition could possibly create hazard subject safety , endanger study procedure interfere interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>